openPR Logo
Press release

Macro and Microeconomic Factors Continue to Impact Bacterial Conjunctivitis Market During 2014 - 2020

11-30-2017 01:32 PM CET | Health & Medicine

Press release from: Transparency Market Research

Macro and Microeconomic Factors Continue to Impact Bacterial

Conjunctivitis also termed as pink eye in the United States and Madras eyes in India is caused due to infection or inflammation of the transparent membrane that covers the part of eyeball and inner surface of eyelids. The name Madras eye was originated in 20th century when adenovirus was discovered in India. Conjunctivitis is most commonly caused due to viral or bacterial infection, exposure to chemical or irritants or allergic reaction. Allergic conjunctivitis is known to be caused due to allergens such as cosmetic smoke, dust mites, pollen, perfumes and balsam of peru. Blurred vision, redness of eye, sensitivity to light, watering or itching of both the eyes, watery discharge from one or both the eyes and feeling of grittiness in one or both the eyes are the major symptoms witnessed in individuals suffering from conjunctivitis.

Report Overview and TOC @ https://www.transparencymarketresearch.com/bacterial-conjunctivitis-market.html

It is a highly contagious disease and is easily spread through sharing of objects like towel and poor washing of hands. The infection can also spread through sneezing or coughing. Thus, kids or adults diagnosed with pink eye are recommended not travel to public places for that period of time. However, conjunctivitis caused due to allergens (caused due to seasonal pollens, cosmetics and perfumes) or chemicals (chemicals, liquids such as furniture polish or bleach) are not contagious. Although, conjunctivitis caused by infections is highly contagious but it does not cause any serious health problem if diagnosed at an early stage. But, if the disease is left untreated then it can lead to permanent vision loss or other serious eye problem. Keratoconjunctivitis is a combination of conjunctivitis and inflammation of cornea while, blepharoconjunctivitis is a combination of inflammation of the cornea and conjunctivitis.

Request brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3771

Bacterial conjunctivitis is one of the major eye problem encountered worldwide and are caused by bacteria’s such as Moraxella and Chlamydia trachomatis. These bacteria’s are responsible for causing persistent conjunctivitis with higher level of redness. Similarly, Staphylococci and Streptococci are witnessed to cause non acute bacterial conjunctivitis. Moreover, bacteria’s such as β-hemolytic streptococci, Neisseria gonorrhoeae and Corynebacterium diphtheriae are other bacterias that are responsible for the production of membranes or psuedomembranes in bacterial conjunctivitis. Most of the cases of bacterial conjunctivitis are acute and self limiting and not a major cause of serious health problem however; due to its high prevalence the infection can have large impact on the society as individuals tend to miss their school or work. Thus, antibiotic, pills, ointment or eyedrops are given to clear the infection. Furthermore, if antibiotics are not showing proper response then swabs for bacterial culture are examined in the laboratories. Generally, fluoroquinolones, macrolides, amynoglycosides, phenicols are prescribed for the treatment of bacterial conjunctivitis. Similarly, tetracyclines or doxycycline are also prescribed for the treatment of infection caused due to Neisseria gonorrhoeae and Chlamydia trachomatis.

For Specific and Customized requirements @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=3771

Conjunctivitis is an extremely common condition with high incidence and low prevalence. The disease can be treated on its own. Hence, exact estimate of epidemlology of this disease is a challenge. However, as per the statistics published by government authority in the U.S approximately 5 million cases of bacterial conjunctivitis are reported due to increasing number of bacterial infections. Moreover, the treatment of disease in the U.S. accounts for approximately USD 589 million annually. It has also been witnessed that out of all the causes of conjunctivitis, bacterial conjunctivitis account for more than 50% of the cases. Thus, rising incidences of bacterial infection would drive the growth of this market.

Allergan, Inc., Merck, Pfizer, Inc., Novartis and others are some of the major players operating in this market segment.

Pre Book full report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=3771<ype=S

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Macro and Microeconomic Factors Continue to Impact Bacterial Conjunctivitis Market During 2014 - 2020 here

News-ID: 839914 • Views:

More Releases from Transparency Market Research

Transformer Dismantling & Recycling Services Market Outlook 2034: How Sustainable Disposal, Circular Materials Recovery, and Grid Modernization Are Driving Global Transformer End-of-Life Management
Transformer Dismantling & Recycling Services Market Outlook 2034: How Sustainabl …
As global energy systems evolve and electricity demand rises, the safe, efficient, and environmentally responsible disposal of aging electrical infrastructure has become an urgent priority. Transformers-critical components of transmission and distribution networks-must be replaced or refurbished regularly due to wear, efficiency loss, safety concerns, or regulatory mandates. Transformer dismantling and recycling services play a vital role in ensuring that these large, complex electrical units are decommissioned safely while valuable materials
Online Dating Services Market Outlook 2034: How Digital Matchmaking Platforms Are Redefining Relationship Building, User Engagement, and Revenue Growth in a Hyperconnected World
Online Dating Services Market Outlook 2034: How Digital Matchmaking Platforms Ar …
The online dating services market has undergone a remarkable transformation over the past decade, evolving from simple matchmaking websites to highly intelligent, data-driven platforms that use artificial intelligence, behavioral insights, and preference-based algorithms to match users more effectively. The rise of mobile apps, digital socialization, and increased acceptance of online dating across age groups has made digital matchmaking a mainstream phenomenon. In 2023, the global online dating services market was
Ambulatory Infusion Centers Market Outlook 2035: Transforming Outpatient Care Through Efficiency, Affordability, and Advanced Therapies
Ambulatory Infusion Centers Market Outlook 2035: Transforming Outpatient Care Th …
Ambulatory infusion centers (AICs) have become one of the most rapidly expanding components of modern healthcare, driven by a growing emphasis on outpatient care solutions, the rising prevalence of chronic diseases, and increasing adoption of advanced biologics. These specialized centers provide infusion therapies outside of hospital settings, offering patients convenience, affordability, and improved treatment experiences. As healthcare systems worldwide shift toward models that prioritize cost savings, patient comfort, and efficient
Amyloidosis Therapeutics Market Outlook 2035: Advancements in Rare Disease Treatment to Drive Market Beyond US$ 6.3 Bn
Amyloidosis Therapeutics Market Outlook 2035: Advancements in Rare Disease Treat …
The global healthcare landscape is witnessing a growing focus on rare diseases, propelled by increasing awareness, expanded diagnostic capabilities, and advancements in personalized medicine. Amyloidosis, a group of rare but severe conditions caused by the buildup of abnormal amyloid proteins in tissues and organs, has moved into the spotlight as medical science uncovers more effective treatments and diagnostic tools. The amyloidosis therapeutics market, valued at US$ 2.7 billion in 2024,

All 5 Releases


More Releases for Bacterial

Prominent Bacterial Conjunctivitis Market Trend for 2025: Innovative Eye Drops T …
What Are the Projected Growth and Market Size Trends for the Bacterial Conjunctivitis Market? The bacterial conjunctivitis market has grown steadily, projected to expand from $4.52 billion in 2024 to $4.76 billion in 2025, at a CAGR of 5.3%. Growth factors include rising bacterial infection cases, improved diagnostics, patient education programs, stringent regulatory frameworks, and physician training. The bacterial conjunctivitis market is projected to grow steadily, reaching $5.54 billion by 2029 at
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can
02-07-2017 | Health & Medicine
TMR
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as